Monitor your progress closely and adjust your approach as needed to achieve optimal results
Our medical team will check in with you to assess your response and answer any questions you may have
Get Free Clinic Match References Korean Ministry of Food and Drug Safety (MFDS / former KFDA) GLP-1 approval records Novo Nordisk Ozempic / Wegovy / Saxenda manufacturer PubMed Semaglutide STEP-1 trial (NEJM 2021, foundational efficacy + safety) FDA Counterfeit Ozempic and Wegovy product safety warning KHIDI Medical Korea MOHW Foreign Patient Attracting Institution registry Important medical disclaimer: GLP-1 medications are prescription drugs with significant risks including pancreatitis, gallbladder disease, gastroparesis, and rare thyroid C-cell tumor risk
Your PlexusDx provider can discuss both options during your consultation and recommend the formulation most likely to succeed based on your lifestyle and medical history
The UK, now outside the EU post-Brexit, is a full Orbis participant meaning British patients with cancer may access new therapies before French or German patients, despite the UK and EU both being wealthy European markets with sophisticated healthcare infrastructure
These changes are related to the weight loss rather than the medication causing it